A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis

Summary

The main purpose of this study is to evaluate the safety and efficacy of LY3541860 in adult participants with multiple sclerosis that gets worse and gets better. The study will last about 9 months with additional 6 months follow-up.

Timeline

Start

2024-03-19

Primary completion

2025-10-18

Completion

2026-07

Drugs

Indications